Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry
Sara J. Schonfeld(National Cancer Institute), Lindsay M. Morton(National Cancer Institute), Lori Muffly(Stanford University), Renata Abrahão(University of California Davis Medical Center), Rafeek A. Yusuf(National Marrow Donor Program), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Bryan Valcárcel(Milken Institute), Eric A. Engels(National Cancer Institute), Paul S. Albert(National Cancer Institute), Rochelle E. Curtis(National Institutes of Health), Ann Brunson(UC Davis Comprehensive Cancer Center), Christa L. Meyer(National Marrow Donor Program), Stephen R. Spellman(National Marrow Donor Program), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Julianne J.P. Cooley(UC Davis Comprehensive Cancer Center), J. Douglas Rizzo, Jeffery J. Auletta(Nationwide Children's Hospital), Theresa H.M. Keegan(UC Davis Comprehensive Cancer Center), Rachel Phelan(Children's Hospital of Wisconsin), Ted Wun(UC Davis Comprehensive Cancer Center)
Cited by 1
Related Papers
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Cancer Burden in the HIV-Infected Population in the United States
|JNCI Journal of the National Cancer Institute|2011|775